Skip to main content
. 2022 Jul 10;84(4):307–319. doi: 10.1055/s-0042-1750178

Table 7. Number and frequency of patients who underwent the various treatment approaches for the management of recurrent or persistent disease.

Count %
Immune checkpoint blockade No 72 72.7%
Yes 27 27.3%
Interferon and/or interleukin No 84 84.8%
Yes 15 15.2%
Chemotherapy No 58 58.6%
Yes 41 41.4%
Surgery No 43 43.0%
Yes 57 57.0%
Radiotherapy No 62 62.6%
Yes 37 37.4%